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Abstract 
Single-stranded DNA (ssDNA) regions form as an intermediate in many DNA-
associated transactions. Multiple cellular proteins interact with ssDNA via the 
oligonucleotide/oligosaccharide-binding (OB) fold domain. The heterotrimeric, 
multi-OB fold domain-containing Replication Protein A (RPA) complex has an 
essential genome maintenance role, protecting ssDNA regions from nucleolytic 
degradation and providing a recruitment platform for proteins involved in 
responses to replication stress and DNA damage. Here, we identify the 
uncharacterized protein RADX (CXorf57) as an ssDNA-binding factor in human 
cells. RADX binds ssDNA via an N-terminal OB fold cluster, which mediates its 
recruitment to sites of replication stress. Deregulation of RADX expression and 
ssDNA binding leads to enhanced replication fork stalling and degradation, and 
we provide evidence that a balanced interplay between RADX and RPA ssDNA-
binding activities is critical for avoiding these defects. Our findings establish 
RADX as an important component of cellular pathways that promote DNA 
replication integrity under basal and stressful conditions by means of multiple 
ssDNA-binding proteins. 
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Synopsis 
RADX/CXorf57 interacts with ssDNA at replication stress sites via N-terminal OB 
fold domains. Through an antagonistic relationship with RPA and other ssDNA-
binding factors, it protects against replication fork degradation and collapse during 
replication stress. 
 
 RADX interacts with ssDNA at sites of replication stress via N-terminal OB 
fold domains. 
 Through its ssDNA-binding affinity, RADX promotes replication fork 
stability during normal S phase and upon replication stress. 
 The balance between RADX and other ssDNA-binding proteins is important 
for DNA replication integrity. 
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Introduction 
Accurate DNA replication during each cell cycle is vital for faithful transmission of 
genetic information and for cell and organism fitness [1, 2]. However, DNA 
replication fidelity is challenged by endogenous and exogenous genotoxic sources 
that jeopardize the integrity and progression of the replication machinery. The 
slowing or stalling of replication forks, a deleterious condition generally referred to as 
replication stress, is a major driver of genomic instability that may lead to cancer and 
other severe pathologies [3-5]. The ATR kinase is a master organizer of the response 
to replication stress, phosphorylating numerous effector proteins to set in motion a 
multipronged protective response to such insults that prevents the detrimental 
breakdown of replication forks [6-8]. Stretches of single-stranded DNA (ssDNA), 
generated by uncoupling of replicative DNA helicase and polymerase activities upon 
insults that hinder polymerase progression, serve as a central trigger of replication 
stress responses [3, 9]. Exposed ssDNA regions are rapidly coated by the ssDNA-
binding heterotrimeric Replication Protein A (RPA) complex, promoting recruitment 
of ATR via its obligate RPA-binding partner ATRIP and subsequent stimulation of its 
kinase activity by activators including TopBP1 and ETAA1 [10-14]. RPA has strong, 
sub-nanomolar ssDNA-binding affinity by virtue of four 
oligonucleotide/oligosaccharide-binding (OB) fold domains, three of which are found 
in RPA1, the largest subunit within the RPA complex [15, 16]. RPA has essential 
functions during both normal DNA replication and responses to genotoxic stress, 
shielding naked ssDNA regions from nucleolytic processing and providing a 
recruitment platform for numerous RPA-binding effector proteins in DNA replication 
and DNA damage responses [16].  
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It is becoming increasingly clear that a major function of the ATR-dependent 
response to replication stress is to prevent irreversible fork collapse by limiting global 
origin firing and, consequently, the overall amount of ssDNA generated [8]. While 
RPA is in considerable excess of the amount needed to globally coat ssDNA exposed 
during unperturbed replication, unscheduled ssDNA generation induced by DNA 
replication inhibitors such as hydroxyurea (HU) can effectively exhaust the cellular 
RPA pool, leaving some replication forks unprotected and susceptible to degradation 
by nucleases [17]. Inhibiting ATR kinase activity exacerbates such irreversible 
replication “catastrophe” by impairing the suppression of new origin firing. The 
notion that RPA is rate-limiting for fork stability during replication stress suggests 
that its availability and dynamic interaction with, and turnover from, ssDNA must be 
carefully controlled in accordance with the status of the genome to ensure faithful 
DNA replication and chromosomal stability, however the underlying mechanisms are 
not well understood. 
   
Besides RPA, eukaryotic cells encode a range of other OB fold domain-containing 
ssDNA-binding factors with important roles in DNA replication and genome 
maintenance pathways [18]. These include SSB1/NABP2, which facilitates DNA 
double-strand break signaling and repair, and POT1 and TPP1, components of the 
telomere-protecting shelterin complex [18]. Another illustrative example is BRCA2, 
an essential mediator of homologous recombination that promotes the exchange of 
ssDNA-bound RPA with the recombinase RAD51 [19]. Recent studies revealed that 
BRCA2 and RAD51 also have key roles in protecting nascent DNA at stalled 
replication forks from degradation by the MRE11 nuclease [20-22]. Thus, it transpires 
that a complex, and in all likelihood highly regulated, interplay between ssDNA and 
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manifold ssDNA-binding proteins operates to safeguard replication fork stability and 
genetic integrity in different chromosomal contexts and in response to a wide range of 
perturbations. 
 
In this study, we discovered that the uncharacterized human protein RADX 
(CXorf57) is a hitherto unrecognized OB fold domain-containing factor that interacts 
with ssDNA regions at DNA replication sites. Through its OB fold-dependent 
ssDNA-binding ability and a functional interplay with RPA, RADX plays an 
important role in supporting the stability of replication forks during normal S phase 
and in response to replication stress. Our findings establish RADX as a new 
component within the range of cellular ssDNA-binding factors promoting DNA 
replication integrity in human cells. 
 
 
Results and Discussion 
RADX (CXorf57) is an ssDNA-binding protein 
In bioinformatic screens for prospective new genome stability maintenance factors, 
we noted that the uncharacterized human protein CXorf57 contains three potential N-
terminal OB folds, a domain organization similar to that of the RPA1 subunit within 
the RPA complex (Fig 1A) [18]. Human CXorf57 has been recently found to be 
among proteins showing enrichment at stalled replication forks and in RPA pull-
downs [23, 24], and the CXorf57 locus is a common integration site for the B-cell 
lymphoma-inducing avian leukosis virus [25]. These observations suggested that 
CXorf57, which we refer to here as RADX, might have a role in DNA replication 
and/or genome stability maintenance pathways, and we therefore explored its cellular 
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function. In silico modeling of RADX structure by the Phyre2 protein modeling suite 
[26] predicted high-confidence similarity of the region comprising OB folds 2 and 3 
in RADX to OB folds within RPA1 and other proteins that bind ssDNA but not RNA 
(Fig 1A,B;EV1A). We therefore asked whether RADX is a DNA-binding protein. 
Using immobilized biotin-labeled DNA oligos, we found that stably expressed wild-
type GFP-RADX was efficiently retrieved in ssDNA pull-downs like RPA1 (Fig 1C). 
Deletion of the entire OB fold region (OB) abolished the ssDNA-binding activity of 
RADX (Fig 1A,C). Importantly, specific point mutations within the RADX OB2 
domain (*OB) predicted to diminish its ssDNA-binding ability based on alignment 
with mutations in the DBD-A OB fold of RPA1 (K263A/E277A) that cause a 100-
fold reduction in ssDNA-binding affinity [27] substantially reduced RADX 
interaction with ssDNA (Fig 1A,C;EV1A). RADX bound ssDNA with high affinity, 
comparable to that of RPA (Fig 1D). Moreover, endogenous RADX interacted with 
ssDNA but not double-stranded DNA (dsDNA) (Fig 1E). These findings suggest that 
the association between RADX and ssDNA is direct and mediated by the OB fold 
region. Interestingly, RADX expression was not cell cycle-regulated but varied 
substantially among human cell lines, in a manner correlating with its mRNA levels 
(Fig 1F;EV1B-D). 
 
To test whether RADX interacts with ssDNA in cells, we performed proximity 
ligation assays (PLA) [28] on BrdU-labeled cell lines stably expressing wild-type 
(WT) or mutant forms of GFP-RADX at similar levels (Fig EV1E,F) to probe for 
proximity between the transgenes and BrdU under native conditions, where the BrdU 
epitope is exclusively accessible in ssDNA [29]. Consistent with RADX associating 
with ssDNA regions via the OB fold domain, we observed specific PLA signals in 
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nuclear foci between BrdU and GFP-RADX WT, but not GFP-RADX OB, in a 
subset of cells, while a smaller proportion of cells expressing GFP-RADX *OB 
displayed PLA foci (Fig 1G,H;EV1G). Likewise, RADX WT but not RADX OB 
associated with chromatin, whereas the *OB mutant showed reduced chromatin 
binding, as judged by its relative distribution between chromatin-enriched and soluble 
fractions (Fig 1I).  
 
OB fold-dependent recruitment of RADX to genotoxic stress sites 
Given the ssDNA-binding ability of RADX, we asked whether it is recruited to sites 
of replication stress, which typically harbor extended ssDNA regions. While 
endogenous RADX was not stably associated with chromatin in unperturbed U2OS 
cells, it could be detected in chromatin fractions upon hydroxyurea (HU)-induced 
replication fork stalling, albeit primarily upon prolonged replication stress that 
induces extensive ssDNA formation (Fig 2A,B;EV2A). In the presence of ATR 
inhibitor, which dramatically increases ssDNA generation and ultimately DNA 
breakage upon HU-induced replication stress [17], RADX chromatin accumulation 
was accelerated along with RPA (Fig 2B;EV2A). Stably expressed GFP-RADX 
predominantly localized to the nucleus, displaying a pronounced puncta-like pattern 
in unstressed cells that required the OB region but did not co-localize with replication 
foci or a range of other nuclear compartments (Fig EV2B,C; our unpublished 
observations). However, we found that WT RADX rapidly accumulated at sites of 
microlaser irradiation-inflicted DNA damage in a subset of cells, co-localizing with γ-
H2AX and PCNA, while the ΔOB mutant showed no detectable recruitment (Fig 
2C,D). Consistent with its residual ssDNA-binding affinity, RADX *OB also 
accumulated at DNA damage sites (Fig 2C). To probe for recruitment of RADX to 
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ssDNA regions upon replication stress, we used PLAs to assay for GFP-RADX 
proximity to RPA, which accumulates strongly at these sites. In line with our earlier 
findings, GFP-RADX WT and *OB, but not RADX ΔOB, gave rise to PLA signals 
with RPA in nuclear foci (Fig 2E,F;EV2D). Importantly, increasing ssDNA formation 
by treatment with HU or camptothecin (CPT) markedly enhanced PLA foci 
specifically in S phase (EdU-positive) cells (Fig 2E,F). We conclude that RADX is 
recruited to ssDNA regions in response to replication stress via its OB fold region.  
 
Loss of RADX deregulates the DNA replication machinery  
The findings above suggested that RADX might promote DNA replication integrity. 
To test this, we performed DNA fiber assays to analyze the impact of RADX loss by 
siRNAs or CRISPR/Cas9-based targeted knockout (Fig 3A,B) on the status of 
individual replication forks. Depletion of RADX in HCT116 cells did not markedly 
affect overall cell cycle distribution and had little impact on checkpoint signaling in 
response to replication stress (Fig EV3A,B). However, we found that RADX 
knockdown by means of different siRNAs markedly reduced fork elongation rates in 
otherwise unstressed cells (Fig 3C). This was accompanied by a substantial decrease 
in the symmetry of bidirectional replication forks (Fig 3D), suggesting that the 
reduced fork speeds in RADX-depleted cells are due, at least in part, to an increased 
rate of fork pausing and stalling events. Indeed, the proportion of stalled forks more 
than doubled in RADX knockdown cells (Fig 3E). Further demonstrating marked 
deregulation of normal DNA replication integrity, RADX depletion caused a dramatic 
increase in new origin usage (Fig 3F), possibly a compensatory effect for the 
diminished replication fork speeds and excessive fork stalling resulting from RADX 
loss [30]. Importantly, the strong impact of RADX siRNAs on replication fork status 
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was closely mirrored by CRISPR/Cas9-mediated RADX knockout (RADX) (Fig 3A-
F), suggesting it was a specific consequence of RADX loss. Moreover, while siRNA-
mediated RADX depletion in U2OS cells essentially mirrored the effects seen in 
HCT116 cells, both of which express RADX at high levels, it only mildly reduced 
fork elongation rates in HeLa cells where RADX expression is low (Fig 1F;EV3C-F).  
 
In addition to its impact on DNA replication in unperturbed cells, depletion of RADX 
led to a defective response to acute replication stress induced by short treatment with 
HU, evidenced by an increased proportion of stalled replication forks and a 
concomitant reduction in the rate of replication fork restart (Fig 3G-I;EV3G). 
Together, these findings demonstrate an important role of RADX in promoting DNA 
replication integrity under both unchallenged and stressful conditions. 
 
The balance between RADX and RPA ssDNA-binding activities is critical for DNA 
replication integrity 
To understand how RADX supports DNA replication integrity, we asked whether its 
ssDNA-binding ability is needed for this involvement. Indeed, using GFP-RADX-
expressing cell lines (Fig EV1E,F), we found that the altered fork elongation and 
origin firing patterns resulting from depletion of endogenous RADX could be fully 
corrected by GFP-RADX WT but not RADX ΔOB, while the RADX *OB mutant 
only modestly ameliorated these defects (Fig 4A-D). The compromised functionality 
of RADX *OB in supporting DNA replication integrity might alter the dynamics of 
its association with ssDNA in cells, potentially explaining why this mutant shows 
enhanced interaction with replication stress sites despite its diminished ssDNA-
binding affinity in vitro (Fig 1C;2E,F). Notably, increasing the expression of RADX 
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WT, but not the ΔOB and *OB mutants, without concomitant depletion of 
endogenous RADX markedly reduced fork speeds in unstressed cells (Fig 4E), 
suggesting that a carefully controlled level of RADX ssDNA-binding activity is 
important for DNA replication integrity. One possible underlying mechanism is that 
RADX has an antagonistic relationship with RPA for interaction with ssDNA regions 
at DNA replication sites that must be properly balanced to ensure efficient fork 
progression. This hypothesis predicted that like RADX, deregulated expression of 
RPA might negatively impact normal DNA replication dynamics. Consistent with this 
idea, in cells where the abundance of the RPA complex was mildly elevated through 
stable ectopic expression of all three RPA subunits at near-endogenous levels (‘Super-
RPA’) [17], replication fork speeds were reduced to an extent comparable to that seen 
in cells lacking RADX (Fig 4E;EV4A). Depletion of RADX aggravated the fork 
progression defect arising from elevated RPA expression (Fig 4E). Mild depletion of 
RPA to an extent that does not impair overall DNA replication capacity [17] similarly 
reduced fork elongation rates, but ameliorated the fork speed, fork symmetry and 
origin firing defects in a RADX background (Fig 4F-H;EV4B). Interestingly, 
knockdown of RAD51 essentially phenocopied these effects (Fig 4F-H;EV4B). These 
findings suggest that via its affinity for ssDNA, RADX might prevent excessive 
associations of ssDNA-binding factors including RPA and RAD51 with replication 
forks to facilitate proper replisome dynamics. However, using iPOND [23] and other 
assays, we did not observe pronounced alterations in RPA and RAD51 interactions 
with replication forks and chromatin upon RADX loss (Fig EV4C; data not shown), 
suggesting that any competition between RADX and these proteins for ssDNA-
binding may be highly dynamic in nature. 
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RADX suppresses replication fork degradation and collapse 
Replication fork components including BRCA2 and RAD51 have critical roles in 
preventing degradation of nascent DNA strands at stalled forks [20, 21]. To test if 
impaired replication fork protection might be an underlying cause of deregulated 
DNA replication integrity induced by RADX deficiency, we monitored the stability of 
newly replicated DNA tracts under HU-induced replication stress (Fig 5A). In these 
assays, RADX knockdown led to a pronounced degree of fork degradation during 
prolonged HU treatment (Fig 5B). Overexpression of WT RADX similarly impaired 
fork protection, while the impact of RADX OB fold mutants were comparatively 
milder (Fig 5C). This suggests that altered replication fork dynamics resulting from 
deregulated RADX expression and ssDNA binding may, at least partially, be a 
consequence of impaired fork protection. Depletion of RADX also led to a markedly 
elevated rate of HU-induced replication catastrophe, characterized by full chromatin 
loading (and thus exhaustion) of the cellular RPA pool and concomitant DNA 
breakage demarcated by H2AX hyperphosphorylation [17] (Fig 5D;EV5A). This 
defect was alleviated by expression of RADX WT but not the *OB mutant (Fig 
5D;EV5A). Strikingly, elevated levels of RPA also mitigated the replication 
catastrophe phenotype caused by RADX loss (Fig 5E). At least two non-mutually 
exclusive scenarios may account for these observations. First, consistent with an 
antagonistic relationship between RADX and RPA for ssDNA binding, RADX 
interaction with ssDNA might enhance RPA mobility at replication forks to increase 
the effective pool of RPA available to bind and protect extended ssDNA regions 
generated upon replication stress, thereby rendering cells less prone to fork breakage. 
Second, RADX may itself have a role in shielding unprotected ssDNA tracts from 
nuclease-mediated degradation, supported by the observation that RADX primarily 
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associates with chromatin upon persistent replication stress. In line with these 
findings, RADX loss caused mild but significant hypersensitivity to replication stress-
inducing agents (Fig 5F,G) similar to the effect of selectively abrogating the fork 
protection function of BRCA2 [21], and this defect could be fully corrected by 
elevated RPA expression (Fig 5H). 
 
Collectively, our work establishes RADX as a novel cellular ssDNA-binding protein 
with an important role in promoting replication fork stability, adding RADX to a 
growing list of OB fold domain-containing factors functioning in DNA-associated 
transactions and genome stability maintenance. Similar findings were recently 
reported by Cortez and colleagues, who demonstrated a role of RADX in 
antagonizing RAD51 accumulation at replication forks to promote genome integrity 
[31]. Our study is consistent with this work and additionally suggests that the 
interplay between RADX and RPA is also important for fork stability. The fork 
protection function of RADX largely correlates with its ssDNA-binding affinity, 
which might help to facilitate optimally balanced fork interactions of ssDNA- and 
RPA-binding factors including RAD51 and SMARCAL1 that centrally influence fork 
remodeling and protection after replication stress [20, 32, 33]. Additional mechanisms 
may also contribute to the role of RADX in promoting DNA replication and 
replication stress responses. For instance, while we have not observed pronounced 
interaction of RADX with RPA, RAD51 and associated genome stability regulators 
(our unpublished observations), RADX might recruit other factors to ssDNA regions; 
indeed, OB fold proteins often form part of multisubunit complexes [18]. Identifying 
cellular binding partners of RADX will be important to address this possibility. The 
highly variable RADX expression pattern among different cancer cell lines raises the 
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possibility that alteration of RADX abundance could be a mechanism to mitigate the 
harmful consequences of chronic replication stress. Future efforts to illuminate the 
mechanistic basis of how RADX facilitates replication fork integrity and stability 
through interplay with cellular binding partners and other ssDNA-binding proteins, 
and how this impacts chromosomal stability in health and disease, are clearly 
warranted. 
 
 
Materials and methods 
Plasmids and siRNAs 
Full-length RADX cDNA was cloned into pCR8/GW/TOPO (Invitrogen) using TOPO 
TA Cloning kit (Invitrogen). Point mutations and deletions in RADX (*OB: 
K304A/E327A; ΔOB: deletion of amino acids 1-495) were introduced with the 
QuikChange Site Directed Mutagenesis Kit (Stratagene), according to the 
manufacturer’s protocol. Using Gateway LR Clonase (Invitrogen) RADX WT, *OB 
and ΔOB cDNAs were inserted into the destination vector pcDNA4/TO/GFP for 
Doxycycline-inducible expression. Plasmids for generation of HCT116 ΔRADX cells 
using CRISPR/Cas9 were generated as described [34] using the pX459 plasmid 
(Addgene #62988) for Cas9 and gRNA delivery. Briefly, gRNA sequences were 
ordered as complementary primers, mixed in a 1:1 ratio and annealed. Subsequently, 
pX459 was digested with BbsI and the gRNA introduced using a normal ligation 
reaction according to the manufacturer’s instructions (New England Biolabs). The 
following sequences were used: RADX sgRNA #2 (forward): 5’-
CACCGACATCATAGCAATAAAGGGG-3’; RADX sgRNA #2 (reverse): 5’-
AAACCCCCTTTATTGCTATGATGTC-3’; RADX sgRNA #3 (forward): 5’-
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CACCGTTAACAGACAAGCAACCTG-3’; RADX sgRNA #3 (reverse): 5’-
AAACCAGGTTGCTTGTCTGTTAAC-3’. 
Plasmid DNA and siRNA transfections were performed using FuGENE HD 
Transfection Reagent (Promega) and Lipofectamine RNAiMAX (Invitrogen), 
respectively, according to the manufacturers’ protocols. All siRNAs were used at a 
final concentration of 50 nM, unless otherwise indicated. The following siRNA 
oligonucleotides were used:  
Non-targeting control (CTRL): 5’-GGGAUACCUAGACGUUCUA-3’;  
RADX(#1): 5’-GCTTGAACTCTCTCGTATA-3’; RADX(#6) (targeting the 3’UTR): 
5’-GGUUCGAAUUUCUCAGUAU-3’; RAD51: 5’-
GUAGAGAAGUGGAGCGUAA-3’. siRNA to RPA1 was described previously [17]. 
Cell culture, drug treatment and colony survival assays 
All cell lines used in this study were obtained from ATCC, cultured in DMEM 
containing 10% FBS and regularly tested for mycoplasma infection. The cell lines 
were not authenticated. To generate U2OS cell lines inducibly expressing GFP-
RADX WT, ∆OB or *OB alleles, U2OS cells were co-transfected with 
pcDNA4/TO/GFP-RADX constructs and pcDNA6/TR (Invitrogen) and positive 
clones were selected by incubation in medium containing blasticidin S (Invitrogen) 
and zeocin (Invitrogen) for 14 days. To generate HCT116 RADXΔ cell lines, parental 
cells were transfected with pX459-sgRADX #2 or #3 (gRNAs targeting unique 
sequences within the RADX locus) and selected briefly with puromycin during clonal 
selection. Clones were screened for RADX expression by immunoblotting. 
The RADXΔ#2 and RADXΔ#3 cell lines were derived independently 
with RADX gRNA #2 and #3, respectively. A U2OS derivative cell line stably 
expressing RPA1, RPA2 and RPA3 at near-endogenous levels from a single transcript 
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(‘Super-RPA’) [17] was a kind gift from Dr. Luis Toledo (Center for Chromosome 
Stability, University of Copenhagen, Denmark). 
Unless otherwise indicated, the following drug concentrations were used: 
camptothecin (1 μM, Sigma Aldrich), hydroxyurea (2 mM, Sigma Aldrich), ATR 
inhibitor (AZ20, 10 μM, Sigma Aldrich), and Doxycycline (1 μg/ml, Sigma Aldrich). 
For colony formation assays, cells were seeded in duplicates (6 cm dishes) per 
condition and allowed to adhere for a minimum of 16 h. Cells were then treated with 
indicated concentrations of HU or CPT for 24 h, washed extensively and incubated in 
drug-free medium for 7-8 days. Plates were then washed once in PBS, left to dry and 
stained with cell staining solution (0.5% w/v Crystal Violet, 25% v/v methanol). 
Finally, the plates were washed three times in deionized water. Colonies were counted 
manually and surviving fraction calculated as: colonies / (seeded colonies x plating 
efficiency). 
Immunoblotting, cell fractionation and antibodies 
For immunoblotting, which was done as described [35], cells were lysed in EBC 
buffer (50 mM Tris, pH 7.5; 150 mM NaCl; 1 mM EDTA; 0.5% NP40; 1 mM DTT) 
or RIPA buffer (50 mM Tris, pH 8.0; 150 mM NaCl; 1% NP40; 0.1% SDS; 0.1% 
sodium deoxycholate) supplemented with protease and phosphatase inhibitors. For 
chromation fractionation, cells were lysed in Buffer 1 (100 mM NaCl; 300 mM 
sucrose; 3 mM MgCl2; 10 mM PIPES, pH 6.8; 1 mM EGTA; 0.2% Triton X-100) 
containing protease, phosphatase and DUB inhibitors and incubated on ice for 5 min. 
After centrifugation, the pellet was washed in Buffer 1 and resuspended in Buffer 2 
(50 mM Tris-HCl, pH 7.5; 150 mM NaCl; 5 mM EDTA; 1% Triton X-100; 0.1% 
SDS) containing protease, phosphatase and DUB inhibitors. Lysates were then 
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incubated 10 min on ice and sonicated. Isolation of replication fork-associated 
proteins by iPOND was done as described [23].  
Antibodies used in this study included: GFP (sc-9996 (Clone B2), Santa Cruz 
(1:1,000 dilution); sc-8334, Santa Cruz (1:5000)), RPA1 (Ab79398, Abcam 
(1:1,000)), RPA2 (ab76420, Abcam (1:1000); NA19L (Clone Ab-3), RPA34-20, 
Calbiochem (1:1,000)), RPA2-pSer4/Ser8 (A300-245A, Bethyl (1:1,000)), RPA3 
(ab588-100, Abcam (1:1000)), γ-H2AX (05-636 (Clone JBW301), Millipore (1:500)), 
Histone H2AX (2595S, Cell Signaling (1:1000)), BrdU (RPN202, GE Healthcare Life 
Sciences (1:5000)), MCM6 (C-20, sc-9843, Santa Cruz (1:1,000)), RAD51 (PC130, 
Ab-1, Millipore (1:500)), Chk1 (sc-8408 (Clone G4), Santa Cruz (1:1,000)), Chk1 
pSer345 (2348, Cell Signaling (1:1,000)), Chk2 pT68 (2661S, Cell Signaling 
(1:1000)), Chk2 (sc-9064, Santa Cruz (1:200)), ATM pS1981 (4526, Cell Signaling 
(1:500)), ATM (ab78 (clone 2C1), Abcam (1:1000)), Tubulin alpha (T9026, Sigma 
Aldrich (1:5000)), Histone H3 (ab1791, Abcam (1:5000)), PCNA (sc-56, Santa Cruz 
(1:500)), Cyclin B (610220, BD Biosciences (1:1000)), Cyclin E (sc-247, Santa Cruz 
(1:1000), Vinculin (V9131, Sigma (1:10,000)). Polyclonal sheep antibody to RADX 
was raised against full-length recombinant human RADX, purified from bacteria. 
Quantification of immunoblots was done with ImageJ software. 
ssDNA-binding assays and RADX OB fold modeling 
For DNA immobilization on beads, a 5’-biotinylated ssDNA oligo (ss90-1-Biotin) or 
reverse complemented non-biotinylated (negative control) ssDNA oligo (ss90-2) was 
incubated with Streptavidin-coated magnetic beads (10 pmol per condition, 
DynaBeads M-280 Streptavidin) in modified EBC buffer (50 mM Tris, pH 7.5; 150 
mM NaCl; 0.5% NP40; 1 mM DTT) at room temperature for 30 min and 
subsequently washed 4 times in modified EBC. For dsDNA pulldowns, ss90-1 and 
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ss90-2 were annealed prior to incubation with beads. For analysis of RADX binding 
to DNA-conjugated beads, U2OS cells stably expressing GFP-RADX alleles were 
lysed in modified EBC buffer supplemented with protease inhibitors. Extracts were 
sonicated and centrifuged at 16.000g. Cleared cell extracts were pre-incubated with 
unconjugated Streptavidin beads at 4 °C for 1 h to reduce unspecific binding. Pre-
cleared extracts were then incubated with ssDNA-conjugated beads for 30 min at 
room temperature and subsequently washed 5 times in modified EBC buffer (or 
modified EBC containing increasing NaCl concentrations). ssDNA-bound proteins 
were eluted by boiling beads in Laemmli Sample Buffer for 10 min and analyzed by 
immunoblotting. DNA oligo sequences: 
ss90-1: 5’-Biotin-
ATCGCATTGGCATTGGCAATGCGATACGACTGATCGAGGGTACTCAGCTA
GCTGATTCCGATCGGCTTATTCCGTGTACATACATCGGAT-3’; ss90-2: 5’- 
ATCCGATGTATGTACACGGAATAAGCCGATCGGAATCAGCTAGCTGAGTA
CCCTCGATCAGTCGTATCGCATTGCCAATGCCAATGCGAT-3’. 
In silico modeling of RADX OB fold domain structure, based on solved OB 
structures and secondary structure prediction, was performed using the Phyre2 protein 
structure prediction server (http://www.sbg.bio.ic.ac.uk/phyre2) [26]. Homology to 
ssDNA-binding OB folds in RPA1, BRCA2, POT1 and SSB1 was detected. Based on 
best model-fit a putative RADX structure of OB folds 2 and 3 (residues 215-506) was 
exported and compared to a published structure of RPA1 DBD-A and DBD-B 
(residues 183-420) bound to ssDNA (PDB code: 4GOP). 
Immunofluorescence, proximity ligation assays (PLA) and high-content imaging 
analysis 
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Cells were pre-extracted in PBS containing 0.2% Triton X-100 for 2 min on ice, 
before fixation with 4% formaldehyde for 10 min. If cells were not pre-extracted, they 
were subjected a permeabilization step with PBS containing 0.2% Triton X-100 for 5 
min and incubated with primary antibodies diluted in DMEM for 1 h at room 
temperature. Following staining with secondary antibodies (Alexa Fluor; Life 
Technologies) diluted in DMEM for 30 min at room temperature, coverslips were 
mounted in Vectashield mounting medium (Vector Laboratories) containing nuclear 
stain DAPI. For EdU staining, cells were treated with EdU (10 μM) for 30 min before 
fixation, then stained using the Click-iT® Plus EdU Alexa Fluor 647 Imaging Kit 
(Invitrogen) according to the manufacturer’s instructions. In situ proximity ligation 
assay (PLA) was performed according to the manufacturer’s guidelines (Duolink). 
Laser microirradiation was performed as described [36]. Confocal images were 
acquired with an LSM880 confocal microscope (Carl Zeiss Microimaging Inc.) 
mounted on Zeiss AxioObserver.Z1 equipped with a Plan Apochromat 40x/1.3 NA oil 
immersion objective, using standard settings. Image acquisition and analysis was 
carried out with ZEN2.1 software. Raw images were exported as TIFF files and if 
adjustments in image contrast and brightness were applied, identical settings were 
used on all images of a given experiment. Quantitative image-based cytometry 
(QIBC) was performed as described [17]. Briefly, cells were pre-extracted or not, 
fixed and stained as described above. Nuclear DNA was counterstained with DAPI 
(Molecular Probes) alongside incubation with secondary antibodies. Cells were 
mounted onto glass slides using ProLong® Gold Antifade (Invitrogen, Molecular 
Probes). Images were acquired with an Olympus IX-81 wide-field microscope 
equipped with an MT20 Illumination system and a digital monochrome Hamamatsu 
C9100 CCD camera. Olympus UPLSAPO 10x/0.4 NA, 20x/0.75 NA objectives were 
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used. Automated and unbiased image analysis was carried out with the ScanR 
analysis software. Unless otherwise stated, between 1000-5000 cells were analyzed 
per condition. Data was exported and processed using Spotfire (Tibco) software. 
DNA fiber assays 
Exponentially growing cells (1x10
6
) were labeled with consecutive pulses of CldU 
(25 M) and IdU (250 M) for 20 min (HCT116) or 25 min (U2OS and HeLa). Cells 
were then trypsinized and resuspended in PBS. Cell suspension (2 l) was spotted 
onto Superfrost glass slides and lysed in buffer containing 200 mM Tris-HCl, pH 5.5; 
50 mM EDTA; 0.5% SDS for 2 min. Slides were tilted at an angle to allow the DNA 
to run slowly down the slide. Slides were air dried before fixing in 3:1 
methanol:acetic acid. DNA fiber spreads were denatured with 2.5 M HCl for 80 min 
before blocking in 2% BSA-PBS with 0.1% Tween for 15 min. Slides were then 
incubated with rat anti-BrdU (Abcam, ab6326) for 1 h at 1:100 to detect CldU. Slides 
were washed in PBS-Tween and PBS before antibody cross-linking in 4% 
formaldehyde for 10 min. Slides were then incubated with Alexa Fluor 594 goat anti-
rat antibody (ThermoFisher) for 1 h at 1:100. Following similar washes, slides were 
incubated with mouse anti-BrdU (BD Bioscience, #347580) at 1:500 overnight at 4º C 
to detect IdU. Slides were washed and incubated with Alexa Fluor 488 goat anti-
mouse antibody (ThermoFisher) for 1 h at 1:100. After washing, the slides were air 
dried and mounted with 50 l of Vectashield mounting medium (Vector 
Laboratories). Track lengths were measured using ImageJ software. For HU 
treatment, cells were incubated with CldU (25 M) for 15 min, followed by 2 mM 
HU for 30 min and finally IdU (250 M) for 30 min before trypsinization and slide 
preparation as above. For fork protection assays, cells were incubated with CldU (25 
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M) for 25 min, followed by IdU (250 M) for 25 min and finally HU (5 mM) for 3 h 
before trypsinization and slide preparation as above. 
Quantification of mRNA levels by quantitative PCR 
RNA was purified from cells using the RNeasy kit (Qiagen). cDNA was generated by 
reverse transcription PCR (iScript™ cDNA Synthesis Kit, Bio-Rad), according to the 
manufacturer’s protocol. Real-time quantitative PCR was performed using the 
Stratagene Mx3005P System and Brilliant III Ultra-Fast SYBR® Green QPCR 
Master Mix (Agilent). Ubiquitin mRNA level was used as a control for normalization. 
For amplification of the indicated cDNAs, the following primers were used: RADX 
(forward): 5′-ATGATGTGACGATCTCAGATGGG-3′; RADX (reverse): 5′-
CCCCTGGCCTATCCTTTTCTC-3′; Ubiquitin (forward) 5′-
CACTTGGTCCTGCGCTTGA-3′; Ubiquitin (reverse) 5′-
CAATTGGGAATGCAACAACTTTAT-3′. 
Statistics and Reproducibility 
For all experiments, samples were not randomized and the investigators were not 
blinded to the group allocation during experiments and outcome assessment. No 
samples were excluded from the analysis and no statistical method was used to 
predetermine sample size. Statistical tests used are described in the figure legends. All 
experiments shown in this study were repeated independently at least twice with 
similar results. Data from representative experiments are shown in Figures 
1C,D,E,F,G,H,I; 2A,B,C,D,E,F; 3A; EV1B,D,E,F,G; EV2A,B,C,D; EV3A,B; 
EV4A,B,C; EV5A,B. 
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Figure legends 
 
Figure 1. 
RADX (CXorf57) is an ssDNA-binding protein 
A. Domain organization of human RADX and RPA1, showing location of OB folds, 
including three DNA-binding domains (DBDs) in RPA1, and RADX mutants used in 
this study (see also Fig EV1A). B. Predicted in silico folding of OB folds 2 and 3 of 
human RADX, modeled by Phyre2, showing similarity to the structure of the region 
encompassing DBD-A and DBD-B in human RPA1 (Fig 1A). C. RADX interacts 
with ssDNA. Extracts of U2OS cells stably expressing GFP-RADX WT or mutants 
were incubated with biotin-coupled ssDNA oligo immobilized on Streptavidin beads, 
washed extensively and immunoblotted with GFP and RPA1 antibodies. D. ssDNA-
bound Streptavidin beads incubated with cell extracts as in (C) were washed with 
buffer containing indicated salt concentrations prior to immunoblotting. E. Lysates of 
untransfected HCT116 cells were incubated with immobilized ssDNA or dsDNA 
probes as in (C) and immunoblotted with RADX and RPA1 antibodies. F. 
Immunoblot analysis of RADX expression in human cell lines. See also Fig EV1B. 
G. Representative images from in situ proximity ligation assays (PLAs) in BrdU-
labeled U2OS and U2OS/GFP-RADX cell lines (Fig EV1E,F) using GFP and BrdU 
antibodies under native conditions. Scale bar, 10 μm. H. Quantification of data in (F) 
by quantitative image-based cytometry (QIBC) (n≥3000 cells per condition; data from 
a representative experiment are shown). See also Fig EV1G. I. Soluble and 
chromatin-enriched fractions of U2OS cell lines stably expressing GFP-RADX alleles 
were immunoblotted with indicated antibodies. 
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Figure 2. 
Recruitment of RADX to sites of replication stress 
A. Immunoblot analysis of chromatin fractions of U2OS cells transfected with 
indicated siRNAs and treated or not with HU. B. U2OS cells treated with HU in the 
presence or absence of ATR inhibitor (ATRi) were fractionated and immunoblotted 
with indicated antibodies. Relative RADX levels on chromatin were quantified and 
normalized to histone H3. See also Fig EV2A. C. Representative images of U2OS 
cells stably expressing indicated GFP-RADX alleles that were subjected to laser 
microirradiation, fixed with methanol/acetone immediately afterwards and 
immunostained with γH2AX antibody. D. As in (C), except cells were fixed with 
paraformaldehyde 20 min after DNA damage infliction and immunostained with 
PCNA antibody. E. Representative images from PLAs with GFP and RPA2 
antibodies in U2OS and U2OS/GFP-RADX cell lines labeled with EdU for 30 min 
and then fixed or exposed to HU or CPT for 4 h before fixation. F. Quantification of 
data in (E) by QIBC (n≥3000 cells per condition; data from a representative 
experiment are shown). See also Fig EV2D. All scale bars, 10 μm. 
 
Figure 3. 
RADX promotes DNA replication integrity 
A. Immunoblot analysis of HCT116 cells transfected with indicated RADX siRNAs 
and RADX knockout cell lines (RADXΔ). B. Schematic for DNA fiber assays in (C-E). 
C. Cells in (A) were labeled with consecutive pulses of CldU and IdU as shown in 
(B). Replication fork speeds were calculated as length of labeled track divided by 
pulse time (bars, mean; n=400 fibers, pooled from two independent experiments, per 
condition). D. Bidirectional replication fork symmetry was calculated as percentage 
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of shorter divided by longer tracks from (C). Concordance is 100%, representing 
equal rates of bidirectional elongation for both daughter forks (bars, mean; n=50 
bidirectional forks, pooled from two independent experiments, per condition). E. 
Proportion of stalled forks (CldU-only tracks) among DNA fibers from (C) (bars, 
mean; 200 fibers analyzed per condition; n=2 independent experiments). F. 
Proportion of new origins (IdU-only tracks) among DNA fibers in (C) (bars, mean; 20 
fields of view quantified per condition; n=2 independent experiments). G. Schematic 
for DNA fiber assays in (H) and (I). H. Proportion of stalled forks (CldU-only tracks) 
among DNA fibers from cells labeled as in (G) (bars, mean; 200 fibers analyzed per 
condition; n=2 independent experiments). I. Proportion of restarted forks (CldU- and 
IdU-positive tracks) among DNA fibers in (G) (bars, mean; 200 fibers analyzed per 
condition; n=2 independent experiments). 
 
Figure 4. 
The balance between RADX and RPA ssDNA-binding activities is critical for 
DNA replication integrity 
A. Replication fork speeds in U2OS or U2OS/GFP-RADX cells transfected with 
control (−) or RADX(#6) siRNA targeting the 3’UTR and labeled with CldU and IdU 
as in Fig 3B (bars, mean; n=400 fibers, pooled from two independent experiments, 
per condition). B. Fork symmetry in cells treated as in (A) (bars, mean; n=50 
bidirectional forks, pooled from two independent experiments, per condition). C. 
Proportion of stalled forks (CldU-only tracks) among DNA fibers in (A) (bars, mean; 
200 fibers analyzed per condition; n=2 independent experiments). D. Proportion of 
new origins (IdU-only tracks) among DNA fibers in (A) (bars, mean; 20 fields of 
view quantified per condition; n=2 independent experiments). E. Parental U2OS and 
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derivative lines stably expressing GFP-RADX alleles or all three RPA isoforms at 
near-endogenous levels (U2OS/Super-RPA) (Fig EV4A) were transfected with 
control (−) or RADX siRNA. Replication fork speeds were determined as in (A) 
(bars, mean; n=400 fibers, pooled from two independent experiments, per condition). 
F. Replication fork speeds in HCT116 cells with indicated genotypes transfected with 
control (−), RPA1 (0.2 nM concentration [17]) or RAD51 siRNAs (Fig EV4B) and 
labeled with CldU and IdU as in Fig 3B (bars, mean; n=400 fibers, pooled from two 
independent experiments, per condition). G. Fork symmetry among DNA fibers in (F) 
(bars, mean; n=50 bidirectional forks, pooled from two independent experiments, per 
condition). H. New origin firing among DNA fibers in (F) (bars, mean; 20 fields of 
view quantified per condition; n=2 independent experiments). 
 
Figure 5. 
RADX promotes replication fork stability and cell survival upon replication 
stress 
A. Schematic for replication fork protection assays in (B) and (C). B. Replication fork 
degradation (IdU/CldU ratio) in U2OS cells transfected with indicated siRNAs and 
processed as in (A) (bars, mean; n=200 fibers, pooled from two independent 
experiments, per condition). C. As in (B), except fork degradation was analyzed in 
U2OS/GFP-RADX cell lines. D. U2OS or U2OS/GFP-RADX cells transfected with 
indicated siRNAs and exposed to HU for 4 h were co-immunostained with RPA1 and 
γ-H2AX antibodies and analyzed by QIBC. Proportion of cells displaying maximal 
RPA chromatin loading accompanied by H2AX hyperphosphorylation (Fig EV5A), 
reflecting replication fork catastrophe [17], is indicated (bars, mean; n=5 independent 
experiments (≥3000 cells analyzed per condition); 
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*P≤0.05,**P≤0.01,***P≤0.001,****P≤0.0001, unpaired t-test). E. As in (D), but 
using U2OS or U2OS/Super-RPA cells exposed or not to HU (n=6 independent 
experiments). See also Fig EV5B. F. Clonogenic survival of U2OS cells transfected 
with indicated siRNAs and subjected to different CPT doses for 24 h 
(mean±SEM;n=3 independent experiments). LQ (Linear Quadratic) model was fitted 
to the fractional survival data, using non-linear least square method. Overlap between 
confidence intervals of the fitting coefficients was used to evaluate the statistical 
difference between cell survival after siRADX and siCTRL treatment (*No overlap of 
95% confidence interval with siCTRL). G. As in (F), except cells were treated with 
indicated doses of HU (mean±SEM;n=3 independent experiments). H. As in (F), 
using U2OS and U2OS/Super-RPA cells (mean±SEM;n=3 independent experiments). 
 
 
 
Expanded View Figure legends 
 
Figure EV1. 
RADX expression, localization and alignment with RPA1 
A. Alignment of the regions comprising OB folds 2 and 3 in human RADX and the 
ssDNA-binding DBD-A and DBD-B OB folds in human RPA1 (Fig 1A). The 
positions of the K263 and E277 residues in RPA1 and the corresponding K304 and 
E327 residues in RADX, mutated in RADX *OB, are indicated by asterisks. B. 
Immunoblot analysis of RADX expression in the indicated human cell lines. C. qPCR 
analysis of RADX mRNA levels in indicated cell lines relative to HCT116 WT cells. 
Primers to ubiquitin were used as a control for normalization (mean±SEM;n=3 
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independent experiments). D. U2OS cells were synchronized in early S phase by 
double thymidine block, released into fresh medium for the indicated times and 
analyzed by immunoblotting with indicated antibodies. E. U2OS cell lines stably 
reconstituted with GFP-RADX alleles were treated or not with Doxycycline (DOX) to 
induce the transgenes and immunoblotted with GFP and Tubulin antibodies. F. Cells 
in (E) were fixed with paraformaldehyde and analyzed by microscopy to visualize 
GFP-RADX localization. Scale bar, 10 μm. G. Quantification of PLAs (Fig 1G,H) in 
BrdU-labeled U2OS and U2OS/GFP-RADX cell lines using GFP and BrdU 
antibodies under native conditions (n≥3000 cells per condition; data from a 
representative experiment are shown).  
 
Figure EV2. 
RADX recruitment to replication stress sites 
A. U2OS cells labeled with BrdU and treated with HU in the presence or absence of 
ATR inhibitor (ATRi) were fixed and immunostained under native conditions. 
Representative images are shown. B. U2OS/GFP-RADX cell lines treated with 
Doxycycline to induce the transgenes were fixed with methanol/acetone and 
immunostained with PCNA antibody. C. As in (B), except cells were pre-extracted 
prior to fixation with paraformaldehyde and immunostained with RPA1 antibody. D. 
Quantification of PLAs (Fig 2E) with GFP and RPA2 antibodies in U2OS and 
U2OS/GFP-RADX cell lines labeled with EdU for 30 min and subsequently left 
untreated or exposed to HU or CPT for 4 h (n≥3000 cells per condition; data from a 
representative experiment are shown). All scale bars, 10 μm. 
 
Figure EV3. 
 31 
Impact of RADX loss on cell cycle distribution, checkpoint signaling and 
replication fork integrity 
A. Quantitative image analysis of asynchronously growing HCT116 cells transfected 
with indicated RADX siRNAs (left) and RADX knockout cell lines (RADXΔ) (right) 
labelled with EdU and stained with DAPI (n≥3000 cells per condition). Proportion of 
cells in different cell cycle phases is indicated. B. HCT116 WT or RADXΔ cells were 
treated with HU or CPT for the indicated times, collected and immunoblotted with 
indicated antibodies. C. U2OS cells transfected with indicated siRNAs were labeled 
with consecutive pulses of CldU and IdU as shown in Fig 3B. Replication fork speeds 
were calculated as length of labeled track divided by pulse time (bars, mean; n=200 
fibers, pooled from two independent experiments, per condition). D. Fork symmetry 
was calculated as the percentage of shorter divided by longer tracks from (C). 
Concordance is 100%, representing fully bidirectional replication and equal rates of 
elongation for both daughter forks (bars, mean; n=50 bidirectional forks, pooled from 
two independent experiments, per condition). E. Proportion of new origins in U2OS 
cells treated as in (C) was determined (bars, mean; 20 fields of view quantified per 
condition; n=2 independent experiments). F. HeLa cells transfected with control 
(CTRL) or RADX siRNA were labeled with consecutive pulses of CldU and IdU as 
shown in Fig 3B. Replication fork speeds were calculated as length of labeled track 
divided by pulse time (bars, mean; n=400 fibers, pooled from two independent 
experiments, per condition). G. U2OS cells transfected with indicated siRNAs were 
labeled with CldU, then incubated with HU, washed and labeled with IdU as shown in 
Fig. 3G. The proportion of new origins was determined (bars, mean; 20 fields of view 
quantified per condition; n=2 independent experiments). 
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Figure EV4. 
RPA and RAD51 expression levels and association with replication forks under 
different experimental conditions 
A. Immunoblot analysis of total extracts of U2OS/Super-RPA cells, using indicated 
antibodies. B. Immunoblot analysis of RPA and RAD51 siRNA knockdown 
efficiency. C. Immunoblot analysis of levels of RAD51, RPA1 and PCNA associated 
with replication forks isolated by iPOND and in total cell extracts in HCT116 WT and 
RADXΔ cell lines.  
 
Figure EV5. 
Impact of altered RADX functionality on HU-induced replication catastrophe  
A. U2OS or derivative U2OS/GFP-RADX cell lines transfected with indicated 
siRNAs and exposed to HU for 4 h were co-immunostained with RPA1 and γ-H2AX 
antibodies and subjected to quantitative image analysis of total RPA1 and mean γ-
H2AX signal intensities in individual cells (each representing a single dot). Cells 
displaying maximal RPA chromatin loading accompanied by extensive DNA 
breakage (characterized by H2AX hyperphosphorylation) reflecting irreversible 
global replication catastrophe are indicated in red. Cells in blue show RPA1 and/or γ-
H2AX signals above background levels. Proportion of cells showing replication 
catastrophe among all cells displaying RPA1 and/or γ-H2AX signals above 
background levels (blue and red) is indicated (n≥3000 cells per condition; data from a 
representative experiment is shown). See also Fig 5D. B. As in (A), but using U2OS 
or U2OS/Super-RPA cells exposed or not to HU. Proportion of cells displaying 
replication catastrophe is indicated (n≥3000 cells per condition; data from a 
representative experiment is shown). See also Fig 5E. 





